Treatment of chronic hepatitis C in a patient with systemic lupus erythematosus.
Péron
Jean-Marie
JM
Zabraniechki
Laurent
L
Pey
François
F
Bureau
Christophe
C
Valmary
Séverine
S
Alaric
Laurent
L
Vinel
Jean-Pierre
JP
D000368:Aged; D000740:Anemia / Q000139:chemically induced; D000998:Antiviral Agents / Q000627:therapeutic use*; D001247:Asthenia / Q000139:chemically induced; D004359:Drug Therapy, Combination; D005260:Female; D006261:Headache / Q000139:chemically induced; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000821:virology; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin